BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31396651)

  • 1. [Insulin therapy-new insulin analogues].
    Ehren M; Klein HH
    Internist (Berl); 2019 Sep; 60(9):887-894. PubMed ID: 31396651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia and insulin analogues: is there a reduction in the incidence?
    Heinemann L
    J Diabetes Complications; 1999; 13(2):105-14. PubMed ID: 10432175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
    Rolla AR; Rakel RE
    Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fast-acting insulin - new developments towards more flexibility for the patient].
    Schmeisl GW; Kretzschmar Y
    MMW Fortschr Med; 2016 Dec; 158(Suppl 6):5-11. PubMed ID: 27933575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
    DeWitt DE; Hirsch IB
    JAMA; 2003 May; 289(17):2254-64. PubMed ID: 12734137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing hypoglycaemia with insulin analogues.
    Heller S
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S31-6. PubMed ID: 12174321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control.
    Christiansen JS; Liebl A; Davidson JA; Ligthelm RJ; Halimi S
    Diabetes Obes Metab; 2010 Feb; 12(2):105-14. PubMed ID: 19895637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premixed insulin treatment for type 2 diabetes: analogue or human?
    Garber AJ; Ligthelm R; Christiansen JS; Liebl A
    Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the treatment of patients with diabetes using insulin analogues: current findings and future directions.
    Lefever E; Vliebergh J; Mathieu C
    Expert Opin Drug Saf; 2021 Feb; 20(2):155-169. PubMed ID: 33249944
    [No Abstract]   [Full Text] [Related]  

  • 10. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New Insulins for Type 1 Diabetes treatment].
    Rumié Carmi HK; Domínguez-Menéndez G; Araya M; Martínez-Aguayo A
    Andes Pediatr; 2023 Jun; 94(3):278-285. PubMed ID: 37909930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The past, present, and future of basal insulins.
    Pettus J; Santos Cavaiola T; Tamborlane WV; Edelman S
    Diabetes Metab Res Rev; 2016 Sep; 32(6):478-96. PubMed ID: 26509843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin analogues: new therapies for type 2 diabetes mellitus.
    Bethel MA; Feinglos MN
    Curr Diab Rep; 2002 Oct; 2(5):403-8. PubMed ID: 12643165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Present and future of insulin treatment].
    Skrha J
    Vnitr Lek; 2013 Mar; 59(3):209-13. PubMed ID: 23713190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rapid-acting insulin analogues insulin glulisine and insulin aspart on postprandial glycemic excursion with single bout of exercise in patients with type 2 diabetes.
    Tanaka N; Hiura Y
    Endocr J; 2015; 62(5):411-6. PubMed ID: 25739586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F; Carabino JM; Vergara CM
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The new insulins].
    Krzentowski G
    Rev Med Brux; 2005 Sep; 26(4):S241-5. PubMed ID: 16240869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety.
    Rolla A
    Am J Med; 2008 Jun; 121(6 Suppl):S9-S19. PubMed ID: 18514090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-acting insulin analogs: progressing slowly].
    Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.